Bristol-Myers Squibb Company

Release Summary

Bristol-Myers Squibb and Nektar Therapeutics Announce Oncology Clinical Collaboration to Evaluate the Combination of Opdivo (nivolumab) and NKTR-214

Bristol-Myers Squibb Company